TKIs: Clinical Trials

5 trials of TKIs, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

4 unknown, 1 recruiting. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Unknown 2

Follow TKIs: new trials by email Literature Review of TKIs trials Research Report on TKIs

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy TKIs - Chronic Myelogenous Leukemia - Chronic Phase		Recruiting	Novartis Pharmaceuticals	1000	2025-12-17	2026-07-20
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma Toripalimab, Axitinib - Neoadjuvant Therapy, Advanced Cancer	Phase 2	Unknown	West China Hospital	40	2020-06-01	2020-05-13
Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study TKIs - Breast Cancer		Unknown	The First Affiliated Hospital with Nanjing Medical University	100	2019-08-01	2022-02-09
Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia TKIs - Leukemia, Lymphoblastic, Acute		Unknown	Nanfang Hospital, Southern Medical University	100	2017-11-01	2017-11-08
TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia TKIs - Philadelphia Chromosome Positive Acute Lymphocytic Leukemia, Stem Cell Transplantation	Phase 2	Unknown	Nanfang Hospital, Southern Medical University	80	2013-06-01	2017-11-08

Conditions studied

Sponsors

Countries

Top investigators

Results publications